Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series

Table 2 Characteristics of patients with refractory disease

Patient	Regimen	Duration of therapy (mos)	UPCR 6 months before RCP	UPCR at RCP initiation
1	MMF & Pred	12	5.2	10.7
2	CsA & Pred	18	NA	11.9
3	CsA & Pred	6	6.8	16.7

Abbreviations: CsA cyclosporine, MMF mycophenolate mofetil, mos months, NA not available, Pred prednisone, UPCR urinary protein: creatinine ratio, RCP rituximab, cyclophosphamide, prednisone

ISSN: 1471-2369